Recent Finacing
Recent Raise
Enterprise Therapeutics is a drug discovery company developing muco-regulatory therapies for CF, COPD and severe asthma using bronchosphere screening and programs targeting ENaC and TMEM16A, advancing ETD001.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Enterprise Therapeutics.